Shares of B2B education services platform, Crizac, made a healthy entry on the bourses, with the stock listing at a premium ...

Indian benchmark indices traded flat on Wednesday as investor sentiment took a hit following U.S. President Donald Trump's ...

Shares of Anthem Biosciences are quoting a premium of more than 12 percent over the IPO price in the grey market.

Viceroy Research report is a malicious combination of selective misinformation and baseless allegations to discredit the ...

Shares of student recruitment solutions provider Crizac Ltd on Wednesday listed with a premium of nearly 15% against the ...

The initial public offering (IPO) of Crizac debuted on the exchanges with a decent premium of almost 15 per cent after ...

Crizac Ltd shares jumped nearly 15% on market debut, trading at Rs 280 on BSE. The IPO, an offer for sale, was subscribed 59.82 times.

Crizac Ltd made a blockbuster debut on the stock exchanges today, July 9, giving its IPO investors listing gains of nearly 15 ...

Shares of Crizac debuted on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on Wednesday, listing at a ...

The price band for the IPO has been fixed between Rs 387 and Rs 407 per share. The IPO will remain open till July 14.

The brokerage noted the IPO is valued at a P/E of 28 times FY25 earnings, and compared to peers, is “fairly priced". With ...

Spearheaded by promoters Pinky Agarwal and Manish Agarwal, the IPO was entirely an offer for sale, targeting no new equity ...